Loading today’s stories
Leadership1 distinct publisher3 min readUpdated
Diligent Market Intelligence says activity held at H1 2025 levels, settlements were the only real route onto boards, and technology brands were pressed on AI integration and cost rationalization.
The Board Room · Leadership desk
Compiled by The Board RoomSomething wrong?How this is made
Shareholder activism in the first half of 2026 did not grow, it changed route: activity held steady at H1 2025 levels despite a fresh wave of market volatility, according to a memorandum from Antoinette Giblin, editorial manager at Diligent Market Intelligence [1][2]. DMI's finding that matters most for boards is procedural: settlements provided the only real path to the boardroom, with few fights going the whole way to a vote as boards and activists looked for common ground in uncertain markets [3].
The newer thesis is thinner but worth reading closely. DMI says AI found its place in the activist playbook, with key technology brands pressed on integration and cost rationalization [4]. The memo names no companies and gives no campaign count, so this is a signal rather than a tally. Note what the phrase couples, though: integration sits next to cost rationalization, which is a demand for evidence of return on spend rather than an argument about roadmap ambition. A board that cannot show what its AI budget has retired, automated or repriced is leaving that narrative to be written by someone with an 8% stake and a slate.
On deals, DMI reports M&A continued to build momentum as an activist lever, with many investors more willing to stand in the way of transactions they viewed as undervalued or poorly timed [5]. STAAR Surgical is the clearest case. Broadwood Capital, a 30% shareholder, led opposition to the medical device maker's combination with Swiss peer Alcon, a deal valued at around $1.5 billion when announced in August 2025 [6][7], arguing STAAR had "sufficient cash, strong demand, new products ready to be launched" [8]. Yunqi Capital and former CEO David Bailey came out against, with Defender Capital and CalSTRS following, and both ISS and Glass Lewis recommended against [9][10]. Broadwood moved on three directors by December [11], and after several postponements and a sweetened bid, the January 6 special meeting saw the sale collapse [12].
Lululemon is the settlement template. Founder and former CEO Chip Wilson, who started the company in 1998, owns around 8% of the shares and left the board in 2015, walked away from a proxy contest in May in exchange for two board seats [13][14][15][16]. His case was product, not capital: he argued the retailer was "losing its soul" through an alleged disinterest in product development, citing quality controversies around the ultra sheer "Get Low" leggings and a 2024 scandal over the Breeze through range design [17][18]. Before the deal was signed, Lululemon had already made leadership changes including naming Nike executive Heidi O'Neill as CEO, succeeding Calvin McDonald in September [19].
Warner Bros. Discovery shows where dissent goes when directors are not the target. Paramount Skydance beat Netflix with an all-cash bid that included the television channels Netflix planned to exclude [20]. Along the way, Pentwater Capital Management threatened to withhold support for directors if Warner failed to engage with Paramount, Paramount raised the prospect of a proxy fight and planned to solicit against the competing Netflix transaction, and Ancora Advisors said it was considering its own contest over Warner's lack of engagement [21][22][23]. The deal passed with overwhelming support on April 23, but the $1.4 billion golden parachute package was rejected with 82% opposition, and the remuneration plan drew 84% opposition at the June annual meeting [24][25][26], two percentage points worse [27].
Watch whether DMI's second-half data attaches named targets and specific asks to the AI thesis, and whether the settlement-first pattern survives a calmer market. Pay votes, meanwhile, remain the cheapest available protest for holders who have already conceded the strategic argument [26].
Follow any of these and your For You feed starts watching them — no settings page required.
Ranked by verification strength, evidence, and original report placement.
M&A continued to build momentum as a lever for activists, with many also more willing to stand in the way of deals they viewed as undervalued or poorly timed.
Shareholder activism proved resilient in the first half of 2026, with activity holding steady at H1 2025 levels despite a fresh wave of market volatility.
The analysis is based on a Diligent memorandum by Antoinette Giblin, Editorial Manager at Diligent Market Intelligence.
Settlements provided the only real path to the boardroom in H1 2026, with few fights going the whole way to a vote as boards and activists worked to find common ground in uncertain markets.
Broadwood Capital, a 30% shareholder in STAAR Surgical, led a campaign against the medical device maker's planned combination with Swiss peer Alcon.
The STAAR-Alcon deal was valued at around $1.5 billion when it was rolled out in August 2025.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
One vendor memo, specific on cases, silent on data
All claims trace to a single source: a Diligent Market Intelligence memorandum republished on the Harvard corporate governance forum. Case-level detail is unusually concrete and falsifiable (named holders, dated meetings, 82% and 84% opposition figures, a $1.5 billion deal value), which lifts the score above a pure-assertion story. But the market-wide framings that carry the headline are unquantified: no campaign counts back 'activity holding steady at H1 2025 levels', no settlement counts back 'the only real path to the boardroom', and the AI claim names nothing at all. There is no second publisher, no company-side response and no underlying dataset, and the captured text is partly degraded.
Behavior visible in named outcomes, not counted
The pattern described is observable in practice, not merely predicted: three named issuers show the H1 2026 shape in dated events, including a sale broken at a special meeting, a founder settled into two board seats, and a deal approved while its parachute package was voted down. That is real, consequential uptake of settlement-first and deal-blocking tactics. It stops short of a high score because the source publishes no counts of campaigns, settlements or votes to size the trend, and the AI-pressure strand has no observed instance whatsoever.
Framing runs ahead of the disclosed evidence
Positive but moderate. The case narratives are well specified and broadly match their headline treatment, but two framings outrun what is shown. 'Settlements provided the only real path to the boardroom' is an absolute stated without settlement or vote counts, and the promoted claim that activists 'started pricing AI' is supported by a single generic sentence while all four detailed campaigns are about M&A, founder governance and climate. The 'wildest campaigns' packaging and the vendor's reference to its own newswire volume also lean promotional relative to the underlying disclosure.
Data vendor writing up its own coverage
The memorandum is authored by Diligent Market Intelligence's Editorial Manager and is, in substance, a showcase for DMI's activism tracking product. The text cites its own newswire's coverage volume on the Lululemon fight ('over a dozen articles') as a marker of significance, and the aggregate trend claims that would most encourage subscription to that dataset are exactly the ones published without figures. The republishing forum discloses the authorship and origin, which is the mitigating factor.
Solid on cases, weak on the thesis
Confidence is moderate and splits by claim type. Dated, named, numeric case facts from a trade-recognized intelligence provider republished on an established governance forum are reasonably reliable and independently checkable against meeting results. The market-level thesis and the AI strand are single-sourced assertions with no data, no corroborating publisher and no dissenting voice, and the degraded capture of the source adds transcription risk. There is only one publisher in the cluster, so nothing here has been cross-checked.
product
ByteDance and the MPA sign a copyright truce, and nobody outside the room can read it2 distinct publishers
invest
The SEC stopped grading exclusions, so issuers now mark their own proxy ballots1 distinct publisher
invest
CNN's editorial-board trial balloon is settlement currency, not governance1 distinct publisher
invest
L3Harris shows what forfeiture can reach, and what it cannot1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 17, 2026